HIGHLIGHTS
- who: Fanqiang Bu and collaborators from the State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing Beijing University of Chemical Technology, Beijing, China have published the Article: Targeted Anti-Biofilm Therapy: Dissecting Targets in the Biofilm Life Cycle, in the Journal: Pharmaceuticals 2022, 1253 of /2022/
- what: In this review the authors focus on the current biofilm-targeting strategies and those under development including targeting persistent cells quorum quenching and phage therapy. The main reason for this is that most biofilm models are constructed from a single strain in the laboratory . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.